@article{4fe7e6caca7f45249a67d50cbc847f22,
title = "The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic.",
keywords = "CYTOKINE STORM, AIRWAY HYPERRESPONSIVENESS, EOSINOPHILIC INFLAMMATION, PLATELET ACTIVATION, ALLERGEN CHALLENGE, LUNG-FUNCTION, CORONAVIRUS, EXPRESSION, DISEASE, PHARMACOKINETICS",
author = "Ludwig Aigner and Frank Pietrantonio and {Bessa de Sousa}, {Diana Marisa} and Johanna Michael and Schuster, {Daniela Brigitte} and Herbert Reitsamer and Horst Zerbe and Michael Studnicka",
note = "Aigner; Bessa de Sousa; Michael: Institute of Molecular Regenerative Medicine, Paracelsus Medical University Salzburg, Salzburg, Austria; Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University Salzburg, Salzburg, Austria; Schuster: Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Paracelsus Medical University Salzburg, Salzburg, Austria; Reitsamer: Department of Ophthalmology and Optometry, University Clinic Salzburg, Paracelsus Medical University, Salzburg, Austria; Research Program of Experimental Ophthalmology and Glaucoma Research, Paracelsus Medical University Salzburg, Salzburg, Austria; Studnicka: Department of Pulmonary Medicine, University Clinic Salzburg, Paracelsus Medical University Salzburg, Salzburg, Austria",
year = "2020",
doi = "10.3389/fmolb.2020.610132",
language = "English",
volume = "7",
pages = "610132",
journal = "FRONTIERS IN MOLECULAR BIOSCIENCES",
issn = "2296-889X",
}